Insider · CIK 0001734295
James A. Robinson Jr.
Files at ELDN (Eledon Pharmaceuticals, Inc.), URGN (UroGen Pharma Ltd.). First filing -, latest -.
James A. Robinson Jr. files SEC Form 4 as director at ELDN (Eledon Pharmaceuticals, Inc.), and also at URGN (UroGen Pharma Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James A. Robinson Jr. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | URGN UroGen Pharma Ltd. | MOption exercise ordinary shares | +2,000 | - | - | 4,000 | Feb 27, 2026 |
| Feb 26, 2025 | URGN UroGen Pharma Ltd. | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 4,000 | Feb 27, 2026 |
| Jan 10, 2026 | ELDN Eledon Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,430 | $0.00 | $0 | 3,430 | Jan 16, 2026 |
| Jan 10, 2026 | ELDN Eledon Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,430 | $0.00 | $0 | 0 | Jan 16, 2026 |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Jan 10, 2035 | ELDN Eledon Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,870 | $0.00 | $0 | 30,870 | Jan 13, 2025 |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +3,430 | $0.00 | $0 | 3,430 | Jan 13, 2025 |
Questions about James A. Robinson Jr.
Answered from the filings on this page, as of the latest one.
Is James A. Robinson Jr. buying or selling?
James A. Robinson Jr. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James A. Robinson Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James A. Robinson Jr. has 0.
Where does James A. Robinson Jr. file Form 4?
James A. Robinson Jr. has filed Form 4 at ELDN (Eledon Pharmaceuticals, Inc.); URGN (UroGen Pharma Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.